Background: Bladder cancer is associated with poor clinical prognosis due to their immunosuppressive microenvironment and therapeutic resistance. Methods: To address the low response rate of immune checkpoint inhibitors (ICIs) and the lack of effective drug de... ...

请注册登录后继续浏览